Protein Summary
The classic group of MBP isoforms (isoform 4-isoform 14) are with PLP the most abundant protein components of the myelin membrane in the CNS. They have a role in both its formation and stabilization. The smaller isoforms might have an important role in remyelination of denuded axons in multiple sclerosis. The non-classic group of MBP isoforms (isoform 1-isoform 3/Golli-MBPs) may preferentially have a role in the early developing brain long before myelination, maybe as components of transcriptional complexes, and may also be involved in signaling pathways in T-cells and neural cells. Differential splicing events combined with optional post-translational modifications give a wide spectrum of isomers, with each of them potentially having a specialized function. Induces T-cell proliferation. The protein encoded by the classic MBP gene is a major constituent of the myelin sheath of oligodendrocytes and Schwann cells in the nervous system. However, MBP-related transcripts are also present in ...more
- ENST00000355994
- ENSP00000348273
- ENSG00000197971
- ENST00000359645
- ENSP00000352667
- ENST00000382582
- ENSP00000372025
- ENST00000397860
- ENSP00000380958
- ENST00000397863
- ENSP00000380961
- ENST00000397865
- ENSP00000380963
- ENST00000397866
- ENSP00000380964
- ENST00000580402
- ENSP00000462223
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
phosphatase | 1 | ||
transcription factor perturbation | 0.99 | ||
hub protein | 0.97 | ||
PubMedID | 0.97 | ||
disease perturbation | 0.93 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 6734.67 (req: < 5)
Gene RIFs: 80 (req: <= 3)
Antibodies: 1187 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 6734.67 (req: >= 5)
Gene RIFs: 80 (req: > 3)
Antibodies: 1187 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 18
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0